| NEOVACS NOM. EO 1,- |
| Frankreich |
| Gesundheit |
| FR0014010856 / A41BPL |
| 0LW0 (Frankfurt) |
| FRA:0LW0, ETR:0LW0, 0LW0:GR |
| - |
| https://www.neovacs.com/ |
|
Neovacs S.A. is a French biotechnology company specializing in the development of therapeutic vaccines, primarily targeting autoimmune, inflammatory, allergy, and cancer diseases. The company’s core innovation lies in its proprietary "Kinoid" techn..
>Volltext.. |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| NEOVACS |
| 05.04.26 |
|